Macter International Limited (MACTER): FY24 Corporate Briefing Takeaways – By Taurus Research
Nov 26 2024
Taurus Securities
- MACTER, a prominent pharmaceutical company in Pakistan, initially established its operations by acquiring the OTC portfolio of MACTER International Limited. Over time, the company expanded its capabilities, transitioning towards a stateof-the-art manufacturing facility. Notably, MACTER is the first and only approved manufacturing facility in Pakistan for the lyophilization of biologicals.
- MACTER reported a revenue of ~PKR 7.5Bn in FY24, marking a 13%YoY increase from ~PKR 6.6Bn in the previous year. However, this growth was partly offset by a planned reduction in government tender participation, leading to a 38% decline in institutional sales. The Company recorded a PAT of ~PKR 427Mn in FY24, reflecting a 9%YoY increase compared to ~PKR 393Mn in the prior year. This growth is attributed to higher contributions from profitable prescriptions, as well as the implementation of efficiency improvements and cost optimization initiatives
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low